Loading...
NPI 1962707166 · Boise, ID · Addiction (Substance Use Disorder) Counselor
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Raise The Bottom Training & Counseling Services, LLC is a addiction (substance use disorder) counselor provider located in Boise, Idaho. This profile covers 2 Medicare and 18 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Raise The Bottom Training & Counseling Services, LLC |
| Address | 9196 W Barnes Dr |
| City | Boise |
| State | ID |
| ZIP | 83709 |
| Taxonomy | Addiction (Substance Use Disorder) Counselor |
| NPI Enumerated | January 19, 2011 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $10.8M |
| Medicare | $241.2K |
RAISE THE BOTTOM TRAINING & COUNSELING SERVICES, LLC is primarily an addiction treatment operator focused on medication-assisted treatment (methadone) and extensive drug testing services; Medicare billing is dominated by G2067 and G2078, which together account for 100.0% of Medicare revenue, while Medicaid revenue is concentrated in G2067 and multiple definitive and presumptive drug-testing codes that together drive the bulk of services. The code mix (G2067 for weekly methadone bundles, plus G0483/G0481/G0482 and 80307 for definitive and presumptive drug testing) indicates the provider operates an opioid treatment program with integrated dispensing/counseling and high-volume laboratory testing. This pattern suggests on-site medication dispensing and routine toxicology monitoring are central to its clinical and revenue model.
Medicaid revenue ($10.8M) far exceeds Medicare revenue ($241.2K), making the organization effectively Medicaid-driven in scale; Medicaid accounts for the vast majority of lifetime revenue reported and the provider should be considered a single-payer-dominant entity with respect to payer mix. This large Medicaid footprint implies the provider’s operational and contractual focus is on state behavioral health and substance-use disorder programs rather than Medicare populations.
Revenue concentration is high on both payers but expressed differently: the top 3 Medicare codes account for 100.0% of Medicare revenue (with G2067 alone representing 97.8% of Medicare revenue), indicating Medicare activity is tightly focused on opioid treatment program services. For Medicaid, the top 3 codes account for 79.9% of Medicaid revenue, with G2067 alone contributing 46.8%, and definitive drug testing codes G0483 and 80307 together representing a substantial share of Medicaid revenue. These shares highlight dependence on a small set of service lines—methadone bundles and high-volume drug testing—for most billed revenue.
Competitive standing differs by payer and code: for Medicare, G2067 billing ranks #222 of 830 providers nationally (73th percentile), indicating a typical, unremarkable national volume for that code rather than market dominance. By contrast, the provider is a clear statewide leader for multiple Medicaid codes: it ranks #1 in-state for G2067, G0483, 80307, G0481, and G0482 (all at the 100th percentile versus in-state peers), signaling dominant volume in Idaho for methadone bundles and both definitive and presumptive drug testing services. These rankings imply the provider is a major local operator for opioid treatment and lab testing within the state.
Several Medicaid codes are labeled as extreme outlier or notably above typical state volume, which underscores unusually high in-state activity in specific services: 80307 is an "extreme outlier, far above typical state volume" and H0001 and 86580 are also flagged as extreme/notably above typical state volume in their respective comparisons. That language, combined with the #1 in-state ranks, indicates the provider performs exceptional volumes of presumptive drug testing (80307) and certain assessment or testing services (H0001, 86580) relative to peers in Idaho. These markers are important for capacity planning, network contracting, and utilization review.
The provider has been Medicare-enrolled (NPI enumerated) since 2011-01-19 (~15 years ago), indicating multi-year operational tenure. That length of enrollment supports the interpretation that its high Medicaid testing and methadone volumes reflect an established, ongoing program rather than a newly launched operation.
Service-level detail shows a mix of bundled programmatic care and discrete clinical services: G2067 captures a weekly bundled opioid treatment program service that includes dispensing, counseling, group therapy, and toxicology if performed, while the suite of G048x and 80307 codes reflect both comprehensive definitive testing (multiple drug classes, GC/MS/LC/MS methods) and high-volume instrumented presumptive screens. The presence of H0004, H0001, and H0003 alongside E/M and psychotherapy codes (99213, 99214, 90834, 90837) indicates the organization also provides assessment, counseling, and some routine outpatient encounters, but these are small revenue contributors compared with medication and lab services.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 1,050 | $220 | $236.1K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 140 | $40 | $5.3K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 2 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
18 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 26,900 | $190 | $5M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 10,430 | $220 | $2.3M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 21,880 | $60 | $1.3M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 10,920 | $110 | $1.2M |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 4,100 | $150 | $619.1K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 3,820 | $40 | $141.3K |
| H0001 | Alcohol and/or drug assessment | 1,890 | $40 | $77.4K |
| H0003 | Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs | 1,180 | $40 | $48.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 520 | $50 | $24.6K |
| 90791 | In this service, the provider performs a psychiatric evaluation of the patient with the aim of making a diagnosis. | 130 | $100 | $13.2K |
Showing 1–10 of 18
How this provider's Medicaid billing volume and revenue compare to other Idaho providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Idaho median
18 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 81 | 160 | 4,020 | $140 | $1.6M |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 1 | 10 | 2,600 | $190 | $1.6M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1 | 10 | 590 | $210 | $598.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 383 | 670 | 740 | $40 | $193.6K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1 | 10 | 850 | $130 | $192.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 449 | 620 | 560 | $60 | $191.8K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1 | 10 | 440 | $110 | $188.4K |
| 90834 | In this service, the provider performs psychotherapy, a series of techniques for treating the psychiatric disorders of the patient. The treatment session with the patient typically lasts for anywhere… | 340 | 410 | 740 | $60 | $174.3K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 1 | 30 | 1,370 | $50 | $121.7K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 182 | 220 | 90 | $80 | $51.4K |
Showing 1–10 of 18
Other providers in the same ZIP code as Raise The Bottom Training & Counseling Services, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.